The links between dementia-related symptoms and the abnormal activation of tyrosine kinase pathways, cardiovascular disease, and impaired insulin sensitivity are reflected by the presence of these agents in the pipeline of repurposed drugs. The gene discussed is INS; the disease is dementia.